Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Singulair (montelukast) carries an FDA boxed warning for serious neuropsychiatric side effects, including agitation, aggression, depression, anxiety, sleep disturbances, nightmares, hallucinations, and suicidal thoughts or actions, which can appear in children and adults and may begin days or even months after starting the drug. More common reactions are milder, such as headache, stomach pain, upper respiratory infection, and fever, while mood and behaviour changes often resolve after stopping the medication under medical guidance. Risk factors, warning signs to watch for in kids, and when to seek urgent help are all important considerations covered in the complete answer below.
If you or your child has noticed mood shifts, sleep problems, or unusual behaviour while taking montelukast, it helps to clarify whether the medication, the underlying asthma or allergies, or something else entirely is driving the change. A free, instant, online symptom check can organize your symptoms into a clear summary, flag anything that needs urgent attention, and help you walk into your next appointment ready to ask the right questions.
Last reviewed for medical accuracy: 10/22/2026
Singulair (montelukast) is a popular prescription medication used to prevent asthma attacks and relieve seasonal allergies. While many people tolerate it well, it carries a rare but important warning about mood and behaviour changes. This article breaks down what you need to know, based on credible sources like the U.S. Food and Drug Administration (FDA) and peer-reviewed studies.
Singulair belongs to a class of drugs called leukotriene receptor antagonists. It works by blocking leukotrienes, inflammatory chemicals your body produces when exposed to allergens or asthma triggers. By reducing inflammation in your airways, Singulair can:
Most patients take a single 10 mg tablet daily. For children under 15, lower doses are available in chewable or granule form.
Like all medications, Singulair can cause side effects. Most are mild and resolve on their own. Common side effects include:
If these symptoms persist or worsen, talk to your doctor. They may adjust your dose or recommend an alternative treatment.
In March 2020, the FDA required a “boxed warning” on montelukast (Singulair) to highlight the risk of serious neuropsychiatric events. Though rare, these events can be severe. They include:
These symptoms have been reported in both adults and children, sometimes within days of starting treatment. In a small number of cases, they persisted or even began after the drug was discontinued.
While most people on Singulair do not experience severe mood changes, studies suggest:
Because these reactions are unpredictable, both patients and caregivers should remain vigilant.
The exact mechanism is not fully understood, but hypotheses include:
More research is needed, but the existing data were sufficient for regulatory bodies to issue warnings.
While anyone taking Singulair could develop neuropsychiatric side effects, certain factors may increase risk:
If you fall into any of these categories, discuss the risks and benefits carefully with your healthcare provider before starting Singulair.
Early detection is key. Patients, parents, and caregivers should watch for:
If any of these occur, stop Singulair immediately and contact a healthcare professional.
For non-urgent concerns or a quick check of your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/).
Singulair remains a valuable option for many with asthma or allergic rhinitis. When used responsibly, its benefits in preventing asthma attacks and controlling allergy symptoms can outweigh the rare risk of neuropsychiatric events. To make an informed choice:
Q: Can I restart Singulair if I had mild mood changes?
A: Only under close medical supervision. If symptoms resolved quickly after stopping, your doctor may try a lower dose or switch treatments.
Q: Are there warning signs in children different from adults?
A: Children might show increased irritability, clinginess, or changes in school performance. Always involve a parent or caregiver in monitoring.
Q: How long after stopping Singulair do mood effects last?
A: Most resolve within days to weeks, but some have reported symptoms lasting longer. Keep in touch with your doctor until you feel back to baseline.
Always take any potential side effect seriously. Contact your healthcare provider immediately if you experience:
Never ignore warning signs, especially if they’re life-threatening or severely impact daily life.
Understanding singulair side effects—especially the mood and behaviour warning—helps you use this medication safely. While most people tolerate Singulair well, remain alert for any neuropsychiatric symptoms. Balance its clear benefits in asthma and allergy control against potential risks, and maintain open communication with your healthcare team. If in doubt, use resources like the free, online symptom check, using the doctor approved Ubie Symptom Checker (https://ubiehealth.com/), and always speak to your doctor about any serious or life-threatening concerns.
(References)
* Ernst P, Ernst G. Neuropsychiatric adverse effects of montelukast in children. Eur Respir J. 2017 Aug;50(2). doi: 10.1183/13993003.01020-2017. Epub 2017 Aug 17. PMID: 28818877.
* Montelukast. 2006. PMID: 30000548.
* Kolkhir P, Grakhova M, Bonnekoh H, Krause K, Maurer M. Treatment of urticarial vasculitis: A systematic review. J Allergy Clin Immunol. 2019 Feb;143(2):458-466. doi: 10.1016/j.jaci.2018.09.007. Epub 2018 Sep 27. PMID: 30268388.
* Kovesi T. Neuropsychiatric side effects of montelukast. J Pediatr. 2019 Sep;212:248. doi: 10.1016/j.jpeds.2019.05.019. Epub 2019 Jun 8. PMID: 31182219.
* Drugs for asthma. Med Lett Drugs Ther. 2020 Dec 14;62(1613):193-200. PMID: 33446622.
* Bubna AK. Leukotriene Antagonists in Dermatology. Indian J Dermatol. 2021 Sep-Oct;66(5):575. doi: 10.4103/ijd.IJD_557_18. PMID: 35068536; PMCID: PMC8751694.
* Jordan A, Toennesen LL, Eklöf J, Sivapalan P, Meteran H, Bønnelykke K, Ulrik CS, Stæhr Jensen JU. Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study. J Allergy Clin Immunol Pract. 2023 Jul;11(7):2096-2103.e1. doi: 10.1016/j.jaip.2023.03.010. Epub 2023 Mar 21. PMID: 36948487.
* Drugs for asthma. Med Lett Drugs Ther. 2024 Nov 25;66(1716):185-192. doi: 10.58347/tml.2024.1716a. PMID: 39558440.
* Lo D, Quint JK. Neuropsychiatric side effects of montelukast: time to change prescribing practice? Thorax. 2024 Dec 23;80(1):1-2. doi: 10.1136/thorax-2024-222643. Epub 2024 Dec 23. PMID: 39578089.
* Wintzell V, Brenner P, Halldner L, Rhedin S, Gong T, Almqvist C. Montelukast Use and the Risk of Neuropsychiatric Adverse Events in Children. JAMA Pediatr. 2025 Apr 1;179(4):418-427. doi: 10.1001/jamapediatrics.2024.5429. PMID: 39836401; PMCID: PMC11976492.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.